Musk's Neuralink registers brain implant study on US government database

Elon Musk's brain-chip startup, Neuralink, has taken a significant step forward by registering a clinical study on the U.S. government's database to evaluate its brain implant in patients. This device is designed to give paralyzed individuals the ability to control digital devices purely through thought, which could greatly benefit those with spinal cord injuries. The study is categorized as a "first-in-human early feasibility study" and aims to enroll three patients.

Neuralink's innovative approach involves using a robot to surgically implant a brain-computer interface (BCI) in the region of the brain that controls movement intentions. The feasibility study, despite being exempt from the requirement to post detailed trial information on the U.S. National Institutes of Health's website, has been registered due to its significance and potential impact. Earlier reports indicate that over 1,000 quadriplegics have signed up for Neuralink's patient registry, demonstrating strong interest and hope within the community.

The first patient to receive the implant, Noland Arbaugh, who was paralyzed from the shoulders down after a diving accident in 2016, has successfully used the device. According to Neuralink's blog posts and videos, the implant has enabled Arbaugh to perform tasks such as playing video games, browsing the internet, and moving a computer cursor by thought alone. This groundbreaking technology holds promise for significantly enhancing the quality of life for individuals with severe physical disabilities.